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Background: An aging population means that chronic illnesses, such as diabetes, are becoming more prevalent
and demands for care are rising. Members of primary care teams should organize and coordinate patient care with
a view to improving quality of care and impartial adherence to evidence-based practices for all patients. The aims
of the present study were: to ascertain the prevalence of diabetes in an Italian population, stratified by age, gender
and citizenship; and to identify the rate of compliance with recommended guidelines for monitoring diabetes, to
see whether disparities exist in the quality of diabetes patient management.
Methods: A population-based analysis was performed on a dataset obtained by processing public health administration
databases. The presence of diabetes and compliance with standards of care were estimated using appropriate algorithms.
A multilevel logistic regression analysis was applied to assess factors affecting compliance with standards of care.
Results: 1,948,622 Italians aged 16+ were included in the study. In this population, 105,987 subjects were identified as
having diabetes on January 1st, 2009. The prevalence of diabetes was 5.43% (95% CI 5.33-5.54) overall, 5.87% (95% CI
5.82-5.92) among males, and 5.05% (95% CI 5.00-5.09) among females. HbA1c levels had been tested in 60.50% of our
diabetic subjects, LDL cholesterol levels in 57.50%, and creatinine levels in 63.27%, but only 44.19% of the diabetic
individuals had undergone a comprehensive assessment during one year of care. Statistical differences in diabetes care
management emerged relating to gender, age, diagnostic latency period, comorbidity and citizenship.
Conclusions: Process management indicators need to be used not only for the overall assessment of health care
processes, but also to monitor disparities in the provision of health care.
Keywords: Health care research, Quality of care, Prevalence, InequalitiesBackground
An aging population means that chronic illnesses, such as
diabetes, are becoming more prevalent and demands for
care are rising. Diabetes mellitus (DM) has become one of
the most important public health challenges of the 21st
century. Over 150 million adults suffer from DM world-
wide, and this number is expected to double in the next
25 years [1,2]. In Italy, it is reported that 12% of Italians
aged over 56 years have been diagnosed with type 2 dia-
betes and the proportion of government healthcare ex-
penditure for diabetes was 14.7% in 2011 [3]. The IDF* Correspondence: alessandra.buja@unipd.it
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reproduction in any medium, provided the orDiabetes Atlas estimated that healthcare expenditure for
diabetes accounted for 11.6% of the total healthcare ex-
penditure worldwide in 2010 [4].
Efforts to guarantee good-quality chronic disease man-
agement in the primary care setting (taking a proactive
population-based approach to address chronic diseases
early in their cycle with a view to preventing their pro-
gression and containing potential related complications)
must begin with the consideration that the vast majority
of patients (e.g. more than 90% of diabetic patients in
the United States [5]) receive the bulk of their care at
primary care practices and are likely to do so for the
foreseeable future. With this in mind, members of pri-
mary care teams should organize and coordinate patient
care with a view to improving quality of care, also with a. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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limiting costly complications and unnecessary proce-
dures [6].
The Diabetes Quality Improvement Project (DQIP)
has developed and implemented a comprehensive set of
performance measures for assessing diabetes care and its
quality improvement that could be widely accepted and
widely implemented. Performance measures retrospect-
ively assess the level of care delivered across the whole
population with diabetes. These measures were defined
on the grounds of several criteria, including credible evi-
dence of a link between these process measures (infor-
mation on the frequency with which a certain laboratory
or clinical test is prescribed) and major clinical out-
comes that can be modified by the health care system’s
efforts and intervention [7]. These measures are already
widely used in surveillance systems for tracking and
monitoring the quality of primary care at population
level. The clinical challenge that remains therefore con-
cerns how to improve physicians’ impartial adherence to
evidence-based practices for all patients, and to monitor
any clinically unjustified, systematic differences and devi-
ations from best care practices.
The aims of the present study were: to ascertain the
current prevalence of patients treated for diabetes, strati-
fied by age, gender and citizenship; to identify the rate of
compliance with recommended guidelines for monitor-
ing diabetes in Italy; and to establish whether disparities
exist in the quality of diabetes patient management. Data
were obtained from the Italian VALORE project, a na-
tional scheme designed with the purpose of assessing
quality of care for chronic diseases and the organization
of primary health care services [8].
Methods
Context
Italy is divided administratively into 20 regions, whose
governments have the important role of fulfilling the ob-
jectives of the National Health Plan at regional level. They
are responsible for planning and organizing health care fa-
cilities and related activities through regional health de-
partments. They also coordinate and control the local
health units (LHU), each of which is an autonomous Na-
tional Health System (NHS) body that organizes and plans
the services in a given area, providing community health
care closer to where people live. The LHUs are organized
into districts that coordinate all NHS and publicly-funded
facilities and services delivered outside the hospital for a
portion of the LHU community.
Participants and dataset
Data for this study were obtained from a research pro-
ject performed between November 2010 and April 2011,
called the “Valutazione dei nuovi modelli organizzatividella Medicina Generale,” (acronym VALORE) and funded
by AGENAS (the Italian national agency for regional
healthcare services) to assess certain organizational fea-
tures of primary care, such as the management of diabetes
mellitus and other chronic diseases, as explained in detail
elsewhere [8]. Six Italian regions, two in northern Italy
(Lombardy and Veneto), three in central Italy (Emilia
Romagna, Tuscany and Marche), and one in southern Italy
(Sicily) took part in the VALORE project. One or two
LHUs in each region were involved in the study (8 in all)
and, for each LHU, two to four district administrations (21
in all) shared their data.
The dataset for analysis was collected on all individ-
uals registered with GPs in each area by automatically
processing routine LHU administrative databases with
the aid of appropriate algorithms.
The cases of diabetes were drawn from this sample using
an algorithm prepared by the Tuscany Regional Public
Health Agency [9], relying on the diagnoses in hospital dis-
charge records, drug usage as recorded in drug dispensing
records, and disease-specific exemptions from health care
copayment, as described in detail elsewhere [10]. Compli-
ance with standards of care was assessed on the basis of
adherence to three requirements established by the OECD
[11] as indicators of the quality of diabetes care at health
system level, i.e.
– at least one HbA1c test a year;
– screening for nephropathy at least once a year;
– at least one LDL cholesterol test a year.
Adherence to these requirements was estimated from
administrative databases recording drug prescriptions
and diagnostic service usage in 2009, as described in de-
tail elsewhere [12]. The reliability of this database was
assessed in recently-published papers, which confirmed
the consistency of the VALORE database [12] used in
the present study with other sources of data, such as pri-
mary care medical records and national surveys.
Statistical analysis
Data were summarized as numbers (percentages) of in-
dividuals for categorical variables. After an appropriate
descriptive analysis, exact two-sided confidence intervals
were constructed based on the binomial proportion.
A multilevel regression model was used to analyze
compliance with standards of care.
All patients lost to follow-up during 2009 were ex-
cluded from this analysis.
The independent variables had a hierarchical structure
with:
– patient level [first-level unit]: gender, age group (16–
44, 45–64, 65–74, 75–84, >85 years old), nationality;
Table 1 Characteristics of the sample
Variables
Gender Female 48.45% (51,356)
Male 51.55% (54,631)




> 85 10.81% (11,462)
Citizenship Italian 96.82% (96,992)
Highly-developed country 0.29% (291)
High migratory pressure country 2.82% (2,820)
Charlson’s index No comorbidities 67.41% (71,451)
Mild comorbidities 13.45% (14,250)
Severe comorbidities 19.14% (20,286)
Time since diagnosis >3 years 66.19% (70,155)
≤ 3 years 33.81% (35,832)
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comorbidity, low comorbidity, severe comorbidity), time
since diagnosis (dichotomized as ≤ 3 years and > 3 years);
– district of residence level [second-level unit].
We classified nationalities as follows: Italians; immi-
grants from highly-developed countries (HDC); immi-
grants from high migratory pressure countries (HMPC)
[13]. The HMPC included new Member States of the
European Union, Africa, Asia (except for Israel and Japan),
and Central and South America; by extension, stateless
people were also included in this group. The HDC in-
cluded the other European countries, North America,
Oceania, Israel and Japan.
The level of statistical significance was set a priori at
p < 0.01 for all analyses. The analyses were all performed
with Stata/SE 12.1.
Ethical issues
The data analysis was performed on anonymized aggre-
gated data without any chance of individuals being identifi-
able. The manuscript complies with the Declaration of
Helsinki and Italian Law n. 196/2003 on the protection of
personal data. The recent Resolution n. 85/2012 of the
Guarantor for the protection of personal data confirmed
permission to process personal data for medical, biomed-
ical and epidemiological research: details concerning health
status can be used as aggregated data for scientific studies
[14]. The dataset used in this study is not publicly available.
Permission to use non-identifiable individual data extracted
from administrative databases for the VALORE project was
granted by the ULSS 16 Padova, the ASP 7 Ragusa, the
Assessorato Politiche per la Salute Emilia Romagna, the
Zona Territoriale Senigallia, the Regione Lombardia, and
the Agenzia Regionale di Sanità della Toscana, which are
responsible for any use of the data concerning their re-
spective populations. A disclosure statement was also sub-
mitted to the ethics committees of the Local Health Units
in the areas participating in the study.
Approval for the use of encrypted and aggregated data
was also obtained from the Italian College of General
Practitioners.
Results
The number of individuals over 16 years old as at 1 January
2009 registered with a GP in the areas considered
amounted to 1,948,622. The case ascertainment algo-
rithm identified 105,987 diabetic patients in this popu-
lation. Table 1 summarizes the characteristics of these
diabetic patients.
The prevalence of diabetes in the population aged ≥16
years was 5.43% (95% CI 5.33-5.54) overall, 5.87% (95% CI
5.82-5.92) among males, and 5.05% (95% CI 5.00-5.09)
among females. Table 2 shows the prevalence of diabetesby age, gender and citizenship. For Italians over 44 years
old, the estimates indicated that women have a signifi-
cantly lower prevalence of diabetes than men. The table
also shows that people from HMPC have a higher preva-
lence of diabetes than Italians, and the difference reaches
statistical significance for adults aged from 45 to 74, in
both males and females.
We found that HbA1c tests had been conducted in
60.50% of our diabetic subjects, LDL cholesterol tests in
57.50%, and creatinine tests in 63.27%, but only 44.19%
of the diabetic individuals had undergone a comprehen-
sive assessment.
Regression analyses were performed on the 102,207 dia-
betic patients who had a full year of follow-up from January
1st to December 31st on 2009. Table 3 shows that differ-
ences in diabetes management were associated with gender,
age, diagnostic latency period, grade of comorbidity and
citizenship. In particular, the table shows that adherence to
all management indicators for diabetes was slightly better
for females than for males, the former having 10% higher
odds of undergoing annual renal function tests. The dia-
betic patients in the retired age group (65–74 year-olds)
had more than twice the odds of undergoing the tests con-
sidered than the youngest age group (16–44). Subjects diag-
nosed ≤ 3 years previously were tested more frequently
than patients with more longstanding diabetes. Diabetics
from HMPC were monitored less than Italian citizens,
while there was no such difference between the latter and
diabetics coming from HDC.
Discussion
This population-based Italian study estimated the preva-
lence of diabetes in the general population. Our prevalence
Table 2 Prevalence of diabetes by gender, age group and citizenship
Citizenship Italian HDC HMPC
(n = 1,710,780) (n = 10,935) (n = 110,402)
Males
16-44 (n = 415,829) 0.59% (95% CI 0.57-0.62) 0.29% (95% CI 0.06-0.52) 1.01% (95% CI 0.91-1.10)
45-64 (n = 296,681) 5.84% (95% CI 5.75- 5.93) 2.94% (95% CI 1.96-3.91) 7.13% (95% CI 6.67-7.59)
65-74 (n = 118,104) 14.65% (95% CI 14.44-14.86) 14.43% (95% CI 10.48-18.37) 19.00% (95% CI 16.45-21.54)
75-84 (n = 76,283) 18.08% (95% CI 17.80-18.37) 16.94% (95% CI 11.50- 22.37) 20.38% (95% CI 15.49-25.28)
85+ (n = 23,994) 16.47% (95% CI 15.98-16.97) 13.46% (95% CI 4.18-22.74) 15.79% (95% CI 4.20-27.38)
Females
16-44 (n = 408,106) 0.65% (95% CI 0.62- 0.68) 0.40% (95% CI 0.19 -0.62) 0.99% (95% CI 0.90-1.09)
45-64 (n = 308,053) 3.64% (95% CI 3.57- 3.71) 1.81% (95% CI 1.29-2.34) 4.54% (95% CI 4.19-4.89)
65-74 (n = 135,675) 10.26% (95% CI 10.09 -10.43) 7.25% (95% CI 5.31-9.18) 15.79% (95% CI 13.86-17.72)
75-84 (n = 111,872) 14.08% (95% CI 13.87-14.30) 12.06% (95% CI 8.76-15.37) 17.96% (95% CI 14.25-21.67)
85+ (n = 54,025) 14.49% (95% CI 14.18 -14.80) 10.56% (95% CI 5.51-15.62) 18.48% (95% CI 10.55-26.41)
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ble those reported by the national public health system’s
service for the ongoing surveillance of the adult popula-
tion, developed by the Italian National Health Institute
(Istituto Superiore di Sanità, ISS), which reported a preva-
lence of 4.96% in the population aged 18-69y in 2009 [15],
and the Italian Statistics Institute (ISTAT) indicated an
overall 4.8% prevalence of diabetes in 2008 [16]. The pop-
ulations investigated in these various estimates differed in
age of enrollment and the methods used to identify cases
of diabetes were also quite different: the present study re-
lied on record-linkage administrative data, whereas the
other above-mentioned statistics were based on telephone
and personal interviews, respectively, indicating self-
reported diagnoses of diabetes.
The prevalence of diabetes by age group in our sample
was similar to the findings of a study on the prevalence of
diabetes in eight European countries [17], and in the US
[18]. The prevalence of the disease decreased in older age,
probably due to the longer survival of non-diabetic people
or to a cohort effect. There was also gender-related differ-
ence, with a higher prevalence of the disease in males than
in females (especially among the older adults). These re-
sults echo previous prevalence estimates conducted in
Europe [17], in the USA (for diagnosed and undiagnosed
diabetes) [19] and in a number of other countries [20].
Our results also indicated that immigrants from HMPC
have a higher prevalence of diabetes than native Italians,
as reported in other studies conducted in Israel [20] and
in the US National Estimates on Diabetes [21] (this report
did not consider immigrant status, but it showed that
Blacks and Hispanics have higher rates of diabetes than
Whites).
The present study showed that almost 40% of the
whole diabetic population in Italy was not monitoredannually in terms of HbA1c, LDL or creatinine levels.
Only a few cross-sectional studies in Europe provide de-
tails on the care process at population level. In a UK
population of patients with diabetes, an HbA1c test had
been done within the previous year in 93.5% of cases, a
serum cholesterol test in 93.1%, and a creatinine test in
93.8% [22,23]. Another study in Israel found that the
care delivered by the health services ensured that almost
85% of patients had annual HbA1c and serum choles-
terol tests [20]. Our results are very similar to those re-
ported in the USA for Medicare beneficiaries on two
quality measures (annual HbA1c testing and lipid profile
measurements) [24], and to the findings of a previous
survey conducted in the Italian city of Torino [25]. The
differences in process performance between different
countries may stem from the way in which primary care
is organized and motivated, showing better results in
countries where ‘pay for performance’ in primary care
schemes are in place, as in the UK. After a quarter of
the income of family practitioners in the UK was tied to
measures of their performance, the Quality and Out-
comes Framework showed that previously-identified
quality improvement trends for major chronic condi-
tions were maintained or increased, but the effect plat-
eaued as physicians gained the maximum rewards
available. For major chronic conditions like diabetes, fi-
nancial incentives should be seen as part of a broader
quality improvement strategy [26]. This philosophy is
consistent with the general literature on quality im-
provement, which suggests that there is no “magic bul-
let”, but multiple interventions sustained over time can
produce major improvements in care [27]. Other issues
may also help to explain the differences in process per-
formance between different countries, such as a different
reliance on of multidisciplinary primary healthcare teams,
Table 3 Multilevel logistic regression with indicators of adherence to diabetes management guidelines as dependent
variables
Annual HbA1c test OR 95% LL 95% UL p
Gender (male = ref.) Female 1.05 1.02 1.08 <0.001
Age group (16-44 = ref.) 45-64 1.73 1.63 1.84 <0.001
65-74 2.14 2.01 2.28 <0.001
75-84 1.78 1.67 1.89 <0.001
85+ 0.98 0.91 1.05 n.s.
Time since diagnosis ≤ 3 years 1.35 1.31 1.38 <0.001
(>3 years = ref)
Charlson’s index(ref. = no comorbidities) Low index 1.05 1.00 1.09 0.030
High index 0.89 0.86 0.92 <0.001
Citizenship (reference = Italian) HDC 0.95 0.75 1.21 n.s.
HMPC 0.74 0.68 0.80 <0.001
Annual screening for nephropathy OR 95% LL 95% UL p
Gender (male = ref.) Female 1.10 1.07 1.14 <0.001
Age group (16-44 = ref.) 45-64 1.47 1.38 1.57 <0.001
65-74 2.11 1.98 2.25 <0.001
75-84 2.30 2.16 2.45 <0.001
85+ 1.60 1.50 1.73 <0.001
Time since diagnosis ≤ 3 years 1.19 1.16 1.23 <0.001
(>3 years = ref.)
Charlson’s index Low index 1.23 1.18 1.28 <0.001
(ref. = no comorbidities)
High index 1.60 1.54 1.70 <0.001
Citizenship (reference = Italian) HDC 1.01 0.79 1.30 n.s.
HMPC 0.77 0.671 0.83 <0.001
Annual LDL cholesterol test OR 95% LL 95% UL p
Gender (male = ref.) Female 1.04 1.01 1.07 0.005
Age group (16-44 = ref.) 45-64 1.71 1.60 1.82 <0.001
65-74 2.11 1.98 2.25 <0.001
75-84 1.69 1.58 1.80 <0.001
85+ 0.80 0.74 0.86 <0.001
Time since diagnosis ≤ 3 years 1.17 1.13 1.20 <0.001
(>3 years = ref.)
Charlson’s index Low index 1.01 0.97 1.05 n.s.
(ref. = no comorbidities)
High index 0.91 0.88 0.94 <0.001
Citizenship (reference = Italian) HDC 0.94 0.74 1.19 n.s.
HMPC 0.65 0.60 0.70 <0.001
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ing their day-to-day self-management, different methods
for training diabetics and their key carers to maintain
effective self-management and monitoring. The differ-
ences in performance in different countries should
encourage international cooperation to facilitate the
exchange of good practice for the purpose of controllingdiabetes by creating a diabetes forum for action and
monitoring [28].
The present study also aimed to identify disparities in
the delivery of care to diabetes patients and it emerged
that gender, age, comorbidities, citizenship and time
since diagnosis were all independent variables explaining
differences in the management of this disease.
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ities in diabetes patients management is still being de-
bated in the literature [29]. In the present study, we
looked instead at the influence of citizenship, gender
and age. Our data show that immigration from a HMPC
reduces the likelihood of a patient’s diabetes being moni-
tored, as shown in another study based on the VALORE
project [30]. Other studies detected racial and ethnic dif-
ferences in the quality of diabetes care too [31,32]. It has
also already been demonstrated that immigrants make
less use of primary care and are less inclined to contact
primary care physicians [33], who are the most often in-
volved in the management of diabetes.
Our data indicate that age is a strong factor influen-
cing the management of diabetes care, irrespective of
the duration of the disease and any comorbidities. The
elderly and younger adults are less likely to be moni-
tored (an abnormal decline in the quality of care for eld-
erly patients has also been reported in some [34,25], but
not all [24] other studies). This has nothing to do with
the availability of evidence-based care, and probably re-
lates to the propensity of individuals to seek primary
care, as demonstrated in a previous study [35]. Younger
adults are likely to be busier in occupational terms and
child care, and less likely to get in touch with their doc-
tors, while the elderly are probably less able to reach a
physician unassisted. Primary care physicians could pro-
vide a more proactive service and actively seek such pa-
tients out. These considerations identify a challenge for
society and health care organizations to find solutions
for any “unequal management” issues [36]. A study on
the impact of a major pay-for-performance initiative in-
troduced in the UK primary care services in 2004 (which
was expected to promote more proactive health care ser-
vices) suggested that younger patients (<45 years old)
with diabetes benefited less in terms of performance
quality and outcomes than older patients, i.e. some age
group disparities persisted [37].
Gender differences in adherence to process perform-
ance measures were small, but emerged consistently for
all processes indicators. Other authors have reported a
higher proportion of females receiving optimal follow-up
than males [20], and one study found gender differences
for diabetes patients also in terms of GP appointments
and prescribed medication, again in favor of female gender
[38]. This better diabetes management in women could be
partly explained by the gender-related difference in the
outcome of the disease, which is known to carry a lower
CVD- and CHD-related mortality risk for men than for
women [39] (though the processes measured concern the
minimum recommended for all patients).
Patients whose diabetes had been diagnosed less than 3
years earlier were monitored more carefully than patients
with a longer history of disease. This applied to all theindicators considered, and to HbA1c testing in particular.
This might be because patients with a relatively recent
diagnosis are more likely to have difficulty in controlling
their disease parameters and consequently need to be
monitored more closely. Alternatively, patients with a
more longstanding disease might be less concerned about
their diabetes and less compliant with their doctor’s rec-
ommendations because their clinical condition has become
stable, giving the impression that they would need moni-
toring less frequently. The recommended minimal tests for
monitoring diabetes should nonetheless be offered to all
patients, irrespective of how long they have been known
to have diabetes.
The present study shows that patients with high comor-
bidity rates were monitored less thoroughly in terms of
HbA1c and LDL tests, than those with no comorbidities.
Another study [25] also found that a cardiovascular event,
for example, distracts the doctor’s and patient’s attention
from the need to monitor their diabetes. The onset of
other medical issues and the arrival on the scene of other
specialists (less sensitive to the diabetes issue) might
plausibly diminish the intensity of diabetes screening.
The main drawback of the present study lies in that it
cannot separate the effects of socio-demographic deter-
minants on diabetes management, distinguishing between
the influence of patients’ socio-demographic features on
their different degrees of adherence to the prescribed
monitoring practices on the one hand, and differences in
physicians’ monitoring practices depending on their pa-
tients’ socio-demographic features on the other. Although
different strategies would be needed to tackle these two
possible causes of shortcomings in health care provision,
the message that comes from the present study – that
efforts are needed to overcome inequalities in diabetes
patient management - is important, whatever the causal
factors involved and their relative contributions.
Our study has other limitations. First of all, not all
socio-economics factors were considered (patients’ for-
mal education was not known, for instance). Secondly,
only process measures were assessed in the present
study, but whether or not closer monitoring is necessarily
linked to better intermediate or final outcomes for diabetes
patients is still being debated [40]. One recent study [41]
found that patients receiving the lowest-quality care, as
measured in terms of the fulfillment of quality-of-care indi-
cators based on screening guidelines similar to those con-
sidered here, carried a higher risk of all-cause mortality and
cardiovascular morbidity than those receiving the highest-
quality care. Another possible shortcoming of our study lies
in that using record linkage may have failed to identify
some diabetic patients. The validity of our record linkage
procedures, based on three administrative sources (records
of hospital discharges, drug prescriptions and payment ex-
emptions for chronic diseases) was addressed in two recent
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data enable disease prevalence to be estimated just as ac-
curately as in other studies conducted in Italy using more
costly and time-consuming methods. Another recent study
[43] showed that using an additional source (the Diabetes
Service’s integrated database) led to the identification of a
higher proportion of diabetics, particularly among the eld-
erly. This could be because patients whose condition is
treated with lifestyle management alone will not be identifi-
able from the administrative databases unless they have ap-
plied for a disease-specific exemption from healthcare co-
payment [11]. Elderly diabetics living in rest homes would
also go undetected because rest homes obtain and dis-
tribute any drugs needed by residents without using pre-
scriptions for named patients. Measures of compliance
with standards of care have shown, however, that these
rest home residents receive much the same care as the
population identified from clinical data collected by gen-
eral practitioners [12].
The strength of our study lies in that it was conducted
using an unrestricted and unselected population of pri-
mary care patients with diabetes mellitus, enabling us to
estimate the prevalence of the disease and primary care
performance measures.
Conclusion
In conclusion, management indicators need to be used
not only for the overall assessment of a process but also
to check for disparities in the provision of health care.
Based on such indicators, the present study pointed to
numerous opportunities for improving diabetes manage-
ment, particularly in younger people, patients with long-
standing disease, and immigrants. Diabetes is growing
significantly and rapidly, so all efforts to take early action
and ensure the impartial management of this disease will
have a major impact on the long-term health and eco-
nomic costs for the diabetic population.
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